Study of Obeldesivir in Children and Adolescents With COVID-19

Stopped early · Phase 2/Phase 3

Conditions studied: COVID-19

In brief

The goal of this clinical study is to learn more about the safety and tolerability of obeldesivir (ODV) in children and adolescents with coronavirus disease 2019 (COVID-19). The primary objectives are to evaluate the plasma pharmacokinetics (PK), safety and tolerability of ODV in pediatric participants with COVID-19.

Key facts

Study ID
NCT05996744
Run by
Gilead Sciences
People needed
3
Starts
2023-12-26
Expected to finish
2024-02-23
Last updated by the study team
2025-02-03

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.